lodotra 1 milligram modified-release tablets
mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 1 milligram
lodotra 2 milligram modified-release tablets
mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 2 milligram
lodotra 5 milligram modified-release tablets
mundipharma pharmaceuticals limited - prednisone - modified-release tablets - 5 milligram
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 10mg; - modified release tablet - 10 mg - active: oxycodone hydrochloride 10mg excipient: ammonio methacrylate copolymer hypromellose lactose monohydrate macrogol 400 magnesium stearate opacode black s-1-17860 povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 15mg; - modified release tablet - 15 mg - active: oxycodone hydrochloride 15mg excipient: ammonio methacrylate copolymer hypromellose iron oxide black lactose monohydrate macrogol 400 magnesium stearate povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 20mg; - modified release tablet - 20 mg - active: oxycodone hydrochloride 20mg excipient: ammonio methacrylate copolymer hypromellose iron oxide red lactose monohydrate macrogol 400 magnesium stearate opacode black s-1-17860 povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 30mg; - modified release tablet - 30 mg - active: oxycodone hydrochloride 30mg excipient: ammonio methacrylate copolymer ferrous oxide hypromellose iron oxide black lactose monohydrate macrogol 400 magnesium stearate povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 40mg; - modified release tablet - 40 mg - active: oxycodone hydrochloride 40mg excipient: ammonio methacrylate copolymer hypromellose iron oxide red iron oxide yellow lactose monohydrate macrogol 400 magnesium stearate opacode black s-1-17860 povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 5mg; - modified release tablet - 5 mg - active: oxycodone hydrochloride 5mg excipient: ammonio methacrylate copolymer brilliant blue fcf hypromellose lactose monohydrate macrogol 400 magnesium stearate opacode black s-1-17860 povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.
oxycodone controlled release tablets
boucher & muir (new zealand) limited t/a bnm group - oxycodone hydrochloride 60mg; - modified release tablet - 60 mg - active: oxycodone hydrochloride 60mg excipient: ammonio methacrylate copolymer erythrosine hypromellose iron oxide red lactose monohydrate macrogol 400 magnesium stearate povidone purified talc purified water stearyl alcohol titanium dioxide triacetin - management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.